(Q36070672)

12 August 2017

2 references

22 October 2022

Treatment and vaccines for severe acute respiratory syndrome (English)

1 reference

12 August 2017

5

Tobias Welte

1 reference

Jan David Alexander Groneberg

12 August 2017

Susan M Poutanen

2

0 references

object named as

David A Groneberg

series ordinal

1

0 references

Donald E Low

series ordinal

3

object named as

Donald E Low

1 reference

12 August 2017

Hartmut Lode

4

1 reference

PubMed ID

15766649

12 August 2017

Peter Zabel

series ordinal

6

1 reference

PubMed ID

15766649

12 August 2017

language of work or name

1 reference

1 March 2005

2 references

Lancet Infectious Diseases

12 August 2017

22 October 2022

2 references

12 August 2017

22 October 2022

5

1 reference

12 August 2017

147-155

1 reference

12 August 2017

3

1 reference

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

12 August 2017

1 reference

12 December 2020

Interference of hepatitis C virus RNA replication by short interfering RNAs

1 reference

12 December 2020

Interferon-beta 1a and SARS coronavirus replication

1 reference

12 December 2020

A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination

1 reference

12 December 2020

Mice susceptible to SARS coronavirus

1 reference

12 December 2020

A cluster of cases of severe acute respiratory syndrome in Hong Kong.

1 reference

12 December 2020

Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study

1 reference

12 December 2020

Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.

1 reference

12 December 2020

Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference

1 reference

12 December 2020

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

1 reference

12 December 2020

The molecular biology of coronaviruses

1 reference

12 December 2020

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets.

1 reference

12 December 2020

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

1 reference

12 December 2020

High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome

1 reference

12 December 2020

Epidemiological and genetic analysis of severe acute respiratory syndrome

1 reference

12 December 2020

Modulation of HIV-1 replication by RNA interference

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

A multicentre collaboration to investigate the cause of severe acute respiratory syndrome.

1 reference

12 December 2020

Severe acute respiratory syndrome: global initiatives for disease diagnosis.

1 reference

12 December 2020

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

1 reference

12 December 2020

The aetiology, origins, and diagnosis of severe acute respiratory syndrome.

1 reference

12 December 2020

Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China

1 reference

12 December 2020

Nidovirales: a new order comprising Coronaviridae and Arteriviridae

1 reference

12 December 2020

Fatal aspergillosis in a patient with SARS who was treated with corticosteroids

1 reference

12 December 2020

Short interfering RNA-directed inhibition of hepatitis B virus replication

1 reference

12 December 2020

Common Adverse Events Associated with the Use of Ribavirin for Severe Acute Respiratory Syndrome in Canada

1 reference

12 December 2020

A major outbreak of severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

Severe Acute Respiratory Syndrome: Clinical Outcome and Prognostic Correlates

1 reference

12 December 2020

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

1 reference

12 December 2020

Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

12 December 2020

Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma

1 reference

12 December 2020

Role of interferons in the treatment of severe acute respiratory syndrome

1 reference

12 December 2020

Role of nitric oxide in chronic allergen-induced airway cell proliferation and inflammation.

1 reference

12 December 2020

Children Hospitalized With Severe Acute Respiratory Syndrome-Related Illness in Toronto

1 reference

12 December 2020

Small molecules targeting severe acute respiratory syndrome human coronavirus

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

Preparing to prevent severe acute respiratory syndrome and other respiratory infections

1 reference

12 December 2020

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.

1 reference

12 December 2020

SARS--one year later.

1 reference

12 December 2020

Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients

1 reference

12 December 2020

Inhibition of SARS-associated coronavirus infection and replication by RNA interference.

1 reference

12 December 2020

Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus

1 reference

12 December 2020

The Biology and Pathogenesis of Coronaviruses

1 reference

12 December 2020

Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China

1 reference

12 December 2020

Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA.

1 reference

12 December 2020

The structure and replication of coronaviruses.

1 reference

12 December 2020

Medicine. Caution urged on SARS vaccines.

1 reference

12 December 2020

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.

1 reference

12 December 2020

Seasonality of infectious diseases and severe acute respiratory syndrome-what we don't know can hurt us.

1 reference

12 December 2020

Treatment of severe acute respiratory syndrome with convalescent plasma

1 reference

12 December 2020

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

1 reference

12 December 2020

How the SARS vaccine effort can learn from HIV?speeding towards the future, learning from the past

1 reference

12 December 2020

Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine

1 reference

12 December 2020

Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide

1 reference

12 December 2020

Nucleic acid vaccines: an overview

1 reference

12 December 2020

SARS: prognosis, outcome and sequelae.

1 reference

12 December 2020

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

1 reference

12 December 2020

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

1 reference

12 December 2020

Aetiology: Koch's postulates fulfilled for SARS virus

1 reference

12 December 2020

Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs

1 reference

12 December 2020

Pro/con clinical debate: steroids are a key component in the treatment of SARS. Con: No, steroids are not a key component of the treatment regimen for SARS

1 reference

12 December 2020

Antiviral treatment of SARS: can we draw any conclusions?

1 reference

12 December 2020

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

1 reference

12 December 2020

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

1 reference

12 December 2020

Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness

1 reference

12 December 2020

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

SARS and Carlo Urbani

1 reference

12 December 2020

Virology: SARS virus infection of cats and ferrets

1 reference

12 December 2020

Effects of a SARS-associated coronavirus vaccine in monkeys.

1 reference

12 December 2020

Clinical trials and novel pathogens: lessons learned from SARS

1 reference

12 December 2020

Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

Avascular necrosis of bone in severe acute respiratory syndrome

1 reference

12 December 2020

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

1 reference

12 December 2020

1 reference

12 December 2020

Morphology and morphogenesis of severe acute respiratory syndrome (SARS)-associated virus.

1 reference

12 December 2020

Induction of inducible nitric oxide synthase and proinflammatory cytokines expression by o,p'-DDT in macrophages.

1 reference

12 December 2020

Novel peptide inhibitors of angiotensin-converting enzyme 2.

1 reference

12 December 2020

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

1 reference

12 December 2020

Collateral damage: the unforeseen effects of emergency outbreak policies

1 reference

12 December 2020

Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha

1 reference

12 December 2020

Lung pathology of fatal severe acute respiratory syndrome.

1 reference

12 December 2020

Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts

1 reference

12 December 2020

Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine

1 reference

12 December 2020

Severe acute respiratory syndrome-associated coronavirus in lung tissue

1 reference

12 December 2020

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

12 December 2020

The Genome sequence of the SARS-associated coronavirus

1 reference

12 December 2020

Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors

1 reference

12 December 2020

HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus

1 reference

12 December 2020

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

12 December 2020

Pro/con clinical debate: steroids are a key component in the treatment of SARS. Pro: Yes, steroids are a key component of the treatment regimen for SARS

1 reference

12 December 2020

10.1016/S1473-3099(05)01307-1

Identifiers

DOI

1 reference

12 August 2017

0 references

1 reference

PubMed ID

15766649